Sino Biopharmaceutical Ltd (SBMFF)
0.43
0.00 (0.00%)
USD |
OTCM |
Nov 14, 16:00
Sino Biopharmaceutical Total Liabilities (Quarterly): 3.382B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.382B |
| June 30, 2024 | 3.382B |
| December 31, 2023 | 3.588B |
| June 30, 2023 | 4.023B |
| June 30, 2023 | 4.023B |
| December 31, 2022 | 3.786B |
| June 30, 2022 | 3.908B |
| June 30, 2022 | 3.908B |
| June 30, 2021 | 3.882B |
| June 30, 2021 | 3.882B |
| March 31, 2021 | 3.692B |
| December 31, 2020 | 3.795B |
| September 30, 2020 | 3.771B |
| June 30, 2020 | 3.786B |
| June 30, 2020 | 3.786B |
| March 31, 2020 | 3.594B |
| December 31, 2019 | 2.423B |
| September 30, 2019 | 2.055B |
| June 30, 2019 | 2.129B |
| March 31, 2019 | 2.007B |
| December 31, 2018 | 1.636B |
| September 30, 2018 | 1.728B |
| June 30, 2018 | 1.613B |
| March 31, 2018 | 1.577B |
| December 31, 2017 | 1.275B |
| Date | Value |
|---|---|
| September 30, 2017 | 1.304B |
| June 30, 2017 | 1.281B |
| March 31, 2017 | 1.266B |
| December 31, 2016 | 1.110B |
| September 30, 2016 | 1.177B |
| June 30, 2016 | 988.44M |
| March 31, 2016 | 924.87M |
| December 31, 2015 | 779.70M |
| September 30, 2015 | 975.38M |
| June 30, 2015 | 967.26M |
| March 31, 2015 | 802.42M |
| December 31, 2014 | 689.11M |
| September 30, 2014 | 699.01M |
| June 30, 2014 | 723.59M |
| March 31, 2014 | 466.82M |
| December 31, 2013 | 353.80M |
| September 30, 2013 | 396.26M |
| June 30, 2013 | 386.17M |
| March 31, 2013 | 319.28M |
| December 31, 2012 | 247.23M |
| September 30, 2012 | 329.14M |
| June 30, 2012 | 294.25M |
| December 31, 2011 | 183.18M |
| September 30, 2011 | 260.90M |
| June 30, 2011 | 270.84M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.423B
Minimum
Dec 2019
4.023B
Maximum
Jun 2023
3.683B
Average
3.786B
Median
Jun 2020
Total Liabilities (Quarterly) Benchmarks
| HUTCHMED (China) Ltd | 508.85M |
| Pharmaron Beijing Co Ltd | 1.420B |
| Regencell Bioscience Holdings Ltd | 0.2195M |
| Prenetics Global Ltd | 42.30M |
| Uni-Bio Science Group Ltd | 22.34M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.177B |
| Shareholders Equity (Quarterly) | 4.519B |
| Debt to Equity Ratio | 0.2896 |
| Current Ratio | 1.149 |
| Net Debt Paydown Yield | 3.90% |